A BREAKTHROUGH IN RESEARCH ON HUMAN
EPIDERMAL GROWTH FACTOR RECEPTOR 2
(HER2) POSITIVE BREAST CANCER USED
A THREE-DRUG COMBINATION TO
PRODUCE MEDIAN SURVIVORSHIP
OF MORE THAN FOUR YEARS.
Breast Cancer Drug
Therapy Findings
Alter Standard of Care
By Carrie Frye
SPECIAL
CLINICAL
SECTION:
WOMEN'S
HEALTH
2 0
|
Long Island MD NEWS ■ M D N E W S . CO M
